SK

Sushant Kumar Sinha

Active Director Director DIN 09814296
DIN 09814296 First appointment Dec 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Sushant Kumar Sinha

Data last updated:

Sushant Kumar Sinha is a Director at Jaguar Super Speciality Hospital Private Limited (since 2022). The company operates in Healthcare.

DIN 09814296
Primary Designation Director
Industry Healthcare
First Appointment 27 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Dec 20222022Active

Directorship timeline

Open interactive timeline →
Jaguar Super Speciality Hospital Private Limited
Premium access

Shareholding and investment profile for Sushant Kumar Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushant Kumar Sinha

Sushant Kumar Sinha currently holds 1 directorship: Jaguar Super Speciality Hospital Private Limited (Director, since 27 Dec 2022).

Sushant Kumar Sinha was first appointed on 27 Dec 2022 as Director at Jaguar Super Speciality Hospital Private Limited.

The current boards of Sushant Kumar Sinha's companies include Chhotu Kumar (Jaguar Super Speciality Hospital Private Limited), Khushbu Kumari (Jaguar Super Speciality Hospital Private Limited), Prashant Kumar Sinha (Jaguar Super Speciality Hospital Private Limited), Shailendra Kumar (Jaguar Super Speciality Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available